Impact of a Dynamic Dressing in the Management of Unoperated Hallux Valgus (DYNHALLUX)

NCT ID: NCT04732897

Last Updated: 2022-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-22

Study Completion Date

2022-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hallux Valgus (HV) is a lateral deviation of the big toe. HV is a deformity of the forefoot centered on the 1st radius (1st metatarsal and big toe). This deformation is characterized by:

* a big toe (hallux) deviated outwards (valgus greater than 12 °)
* a first metatarsal moved medially (varus) (angle M1 / M2\> 10 °). We also note the existence of an exostosis formed by the apex of the angle between the 1st metatarsal deviated inwards and the big toe deported outwards. This exostosis corresponds to the head of the 1st metatarsal.

In addition to the pain and the unaesthetic nature induced by this deviation, the modifications of the skeletal axes of the foot cause disorders of its function but also of the joints of the lower limb during standing, walking and running. Axis defects of the lower limbs in varum or valgum also cause deformities in the rearfoot, midfoot and forefoot.

There is no non-surgical curative treatment for this deformity. Different conservative treatment options have been offered for first-line treatment, including different types of physiotherapy, wearing rigid insoles or splints.

Wearing rigid insoles is indicated to "counter" the valgic pressure, thereby reducing pain and high plantar pressure, in patients with HV. Their hardness, expressed in SHORE units, must be greater than 65. By countering the valgic pressure (rearfoot and midfoot), the rigid soles make it possible to contain the development of deformation and stabilize the axis of the first spoke. The speed of hallux deformation is therefore greatly reduced if the soles are worn diligently. But there is little or no impact on the correction of the deformity, but it is stabilized as it is without rapid and major worsening. Indeed, soles with a hardness greater than or equal to 65 SHORE make it possible to avoid the valgum of the hindfoot and midfoot under load and when walking.

Wearing a dynamic splint was studied in a recently published prospective randomized study conducted between 2011 and 2013. This study, concluding that the dynamic splint is not effective in reducing the angle of deformation of the HV, nevertheless shows the reduction in pain during walking and running. The limits of the study lie in the pace of wearing the splint, left to the discretion of patients, during their rest period, and in the duration of the operation, which is not precisely described.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hypothesis of the study is that a dynamic joint dressing, associated with a rigid orthopedic insole, would make it possible to "reverse" the deformation and re-focus the angles of deformation of the first ray in patients with a HV and already stabilized, i.e. wearer of made-to-measure soles with SHORE greater than or equal to 65 for at least 2 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hallux Abductovalgus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Open-label randomized trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control arm

wearing made-to-measure soles with SHORE greater than or equal to 65 (standard of care)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventional arm

wearing made-to-measure soles with SHORE greater than or equal to 65 + dynamic dressing of the joint

Group Type EXPERIMENTAL

dynamic dressing

Intervention Type PROCEDURE

Dynamic dressing is made by bandages of the foot with gauze pad, stretchable adhesive tape and elastic compression band

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dynamic dressing

Dynamic dressing is made by bandages of the foot with gauze pad, stretchable adhesive tape and elastic compression band

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hallux valgus on at least one foot theoretically requiring surgical management within 12 months
* reducible hallux valgus
* wearing custom-made orthopedic insoles made by a biomechanical podiatrist - SHORE ≥ 65 - for at least 2 months at the time of inclusion
* beneficiary of a social security scheme
* informed of the study and signed informed consent form

Exclusion Criteria

* History of hallux valgus correction surgery on the affected foot
* History of traumatic lesion of the M1-P1 metatarsophalangeal joint of the affected foot
* Skin pathology limiting or contraindicating the possibility of dressings according to the judgment of the investigator (eg dyshidrotic eczema, psoriasis or other problematic skin damage located in the foot)
* Acute bursitis
* Clinical and / or radiological stage 1 or more osteoarthritis according to the criteria of Kellgren and Lawrence
* Non-stabilized diabetes and / or diabetes with micro / macrovascular complications
* Patients with neuropathy
* History of gout
* History of rheumatic pathology
* Obliterating arteriopathy of the lower limbs of stage II or more according to the classification of Leriche and Fontaine
* Pregnant woman
* Patients under tutorship or curatorship
* Patients under legal protection
* Patients who do not understand French
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Annecy Genevois

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guy Allamel, PhD

Role: PRINCIPAL_INVESTIGATOR

CH Annecy Genevois

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Annecy Genevois

Metz-Tessy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-45

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.